## HSY: The Hershey Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 0.3% below STRENGTH zone (4.0-10.0%); PEG 48.57 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($178.57)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Hershey (HSY) Stock Declines While Market Improves: Some Information for Investors**
- Source: Yahoo Finance Singapore | 20251222T230932 | Somewhat-Bearish | Relevance: 100%
- Hershey (HSY) stock closed down 1.52% on the most recent trading day, underperforming the S&P 500, Dow, and Nasdaq. Despite this recent decline, the company's shares had gained 1.75% over the past month, outperforming the Consumer Staples sector. Investors are awaiting Hershey's upcoming earnings report, with forecasts predicting a decrease in EPS but an increase in revenue compared to the prior year.

**2. Who Owns The Hershey Company? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20251220T220838 | Somewhat-Bullish | Relevance: 100%
- The Hershey Company (NYSE: HSY) is a global consumer staples business with a market value of around $38.4 billion, supported primarily by large institutional investors like The Vanguard Group and BlackRock. While institutional holdings provide stability, some active managers are adjusting positions, reflecting varied views on valuation. Insider trading activity appears balanced and modest, suggesting no strong directional conviction.

**3. Hershey (HSY): Reassessing Valuation After Morgan Stanleyâ€™s Overweight Upgrade and Earnings Growth Outlook**
- Source: Yahoo Finance | 20251220T171100 | Somewhat-Bullish | Relevance: 100%
- Morgan Stanley's upgrade of Hershey (HSY) to Overweight suggests that easing cocoa costs, improving fundamentals, and recent snack acquisitions could drive multiyear earnings growth. Despite some momentum, the market's current valuation of HSY shares, trading at 28.2 times earnings compared to a 23 times fair ratio and 19.4 times for the US Food industry, raises questions about whether the recovery is already priced in. The article encourages investors to analyze whether Hershey is still undervalued or if it's drifting into valuation risk due to its rich earnings multiple.

**4. GIS - General Mills, Inc Stock Price and Quote**
- Source: Finviz | 20251220T060812 | Neutral | Relevance: 61%
- This article provides a comprehensive overview of General Mills, Inc. (GIS) stock, including its latest price, financial metrics, insider transactions, and a list of recent news and analyst ratings. It highlights key financial data such as market capitalization, P/E ratio, dividend yield, and performance metrics over various periods, alongside recent analyst actions and company news.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 5, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | B of A Securiti | $210 | $200 | +5% |
| 2025-12-19 | Piper Sandler | $193 | $180 | +7% |
| 2025-12-15 | Morgan Stanley | $211 | $195 | +8% |
| 2025-12-11 | Stifel | $195 | $185 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | B of A Securiti | main | Neutral |
| 2025-12-19 | Piper Sandler | main | Neutral |
| 2025-12-15 | Morgan Stanley | up | Overweight |
| 2025-12-11 | Stifel | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 15 ($0.50M) |
| Sells | 4 ($1.63M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 83.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Hershey Trust Compan: 38.2% (0.0%)
- Vanguard Group Inc: 12.7% (+0.2%)
- Blackrock Inc.: 8.2% (-1.4%)
- Capital Internationa: 6.0% (-16.2%)
- State Street Corpora: 4.9% (+1.8%)

### Key Risks

1. Valuation stretched: PEG 48.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 5 raises (avg +6%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 48.57 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 31%). Analyst sentiment positive (5 raises, avg +6%). Insider selling cluster ($1.6M in 90 days), potential headwind. Institutional flow bearish (3 selling vs 6 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $37.8B |
| Beta | 0.18 |
| 52W Range | $140.13 - $199.00 |
| Short Interest | 6.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 48.57 |
| Forward P/E | 26.9 |
| Current P/E | 31.1 |
| YoY Growth | 15.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.5% to 0.3% (-2.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.7pp (needs >4.0% for momentum thesis). MRS_5 (-2.3%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56. Elevated volume (1.3x 20MA), institutional activity likely. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.28% (CS: 50) | Neutral |
| RSI_14 | 55.5 | Neutral |
| MACD Histogram | 0.49 | Bullish |
| vs SMA20 | 1.009x | Above |
| vs SMA50 | 1.028x | Above |
| vs SMA200 | 1.059x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $186.35
- **Stop Loss:** $178.57 (4.2% risk)
- **Target:** $194.13 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 77
- **Position Value:** $14,348.95
- **Portfolio %:** 14.35%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-05 (Est: $1.39)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.06 | $1.30 | +22.2% |
| 2025Q2 | $1.00 | $1.21 | +20.4% |
| 2025Q1 | $1.93 | $2.09 | +8.0% |
| 2024Q4 | $2.38 | $2.69 | +13.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*